Form 4: Oric Pharmaceuticals Director Angie You Acquires Stock Options

Director Angie You acquired stock options for 25,600 shares of Oric Pharmaceuticals on June 12, 2024.

Summary

• On June 12, 2024, Angie You, a director of Oric Pharmaceuticals, acquired stock options for 25,600 shares.
• The exercise price of these options is $7.90.
• The options vest on the earlier of June 12, 2025, or the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.
• The options expire on June 11, 2034.
• Following the transaction, Angie You directly owns options for 25,600 shares of Oric Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to a director, which is neither particularly positive nor negative on its own.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.

Stakeholder Impact

• The granting of stock options to a director can align their interests with those of the shareholders.

Key Dates